We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

Deaths Caused by the 2009 Flu Pandemic Greatly Exceeded WHO Estimates

By HospiMedica International staff writers
Posted on 09 Dec 2013
Image: Electron micrograph showing the 2009 H1N1 virus (Photo courtesy of the CDC - [US] Centers for Disease Control and Prevention).
Image: Electron micrograph showing the 2009 H1N1 virus (Photo courtesy of the CDC - [US] Centers for Disease Control and Prevention).
A new estimate suggests that the global death toll from the 2009 outbreak of the H1N1 virus to be 10 times higher than the World Health Organization’s reckoning, which was based only on laboratory-confirmed cases.

A team of researchers comprising more than 60 collaborators in 26 countries analyzed weekly virology data from the World Health Organization (WHO) FluNet database and national influenza centers to identify influenza active periods, and obtained weekly national underlying cause-of-death time series for 2005–2009 from collaborators in more than 20 countries (35% of the world's population).

The investigators employed a multivariate linear regression model to measure the numbers and rates of pandemic influenza respiratory deaths in each of these countries. Then, in the second stage of their analysis, they used a multiple imputation model that took into account country-specific geographical, economic, and health indicators to project the single-country estimates to all world countries.

The WHO reported 18,631 laboratory-confirmed pandemic deaths, but the total pandemic mortality burden was substantially higher. The results of the current study yielded an estimate that between 123,000 and 203,000 pandemic influenza respiratory deaths occurred globally from April 1, 2009, through December 31, 2009. Most of these deaths (62%–85%) occurred in people younger than 65 years old. There was a striking regional heterogeneity in deaths, with up to 20-fold higher mortality in Central and South American countries than in European countries. The model attributed 148,000–249,000 respiratory deaths to influenza in an average prepandemic season. Notably, only 19% of these deaths occurred in people younger than 65 years old.

“This study confirms that the H1N1 virus killed many more people globally than originally believed,” said first author Dr. Lone Simonsen, professor of global health epidemiology at George Washington University (Washington DC, USA). “We also found that the mortality burden of this pandemic fell most heavily on younger people and those living in certain parts of the Americas.”

“Whenever a new influenza virus emerges the ensuing outbreak can represent a crisis—with rapidly spreading illness and death that spreads from country to country,” said Dr. Simonsen. “The 1918 Spanish influenza pandemic, for example, killed approximately 2% of the world population at the time or a staggering 50 million. Although the H1N1 flu did not come close to causing that high casualty rate, understanding the global impact of such a pandemic remains vitally important in order to plan and prepare for the next time a pandemic virus emerges.”

The study was published in the November 26, 2013, online edition of the journal PLOS Medicine.

Related Links:

George Washington University
World Health Organization (WHO) FluNet database


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Fetal Monitor
BT-380
Syringe Pump
SP50 Series

Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more